期刊文献+

罗红霉素联合布地奈德气雾剂治疗支气管哮喘的疗效观察 被引量:6

Observation of effects of asthmatic patients treated with roxithromycin combined with budesonide aerosol
下载PDF
导出
摘要 目的观察罗红霉素辅佐布地奈德气雾剂治疗支气管哮喘的临床疗效以及对诱导痰中炎性细胞变化的影响。方法50例门诊支气管哮喘患者分为2组:布地奈得气雾剂治疗组为A组,罗红霉素联合布地奈德气雾剂治疗组为B组,比较其治疗前后临床症状及诱导痰中炎性细胞的变化。结果与A组相比,B组治疗后哮喘患者发作次数,病情程度,肺功能检查均明显减轻(P<0.05),诱导痰中炎性细胞变化亦显著减少(P<0.05)。结论罗红霉素联合布地奈德气雾剂治疗支气管哮喘能取得较好的疗效。 Objective To observe the clinical efficiency and influence of inflammatory cells in the induced sputum of asthmatic patients treated with roxithromycin combined with budesonide aerosol. Methods 50 eases with asthma were clinically devided into two groups: Group A treated with budesonide aerosol and group B treated with roxithromyein combined with budesonide aerosol. Changes of the clinical efficiency and influence of inflammatory cells in induced sputum were analysed. Results Compared with group A,the onset frequency,the severity and pulmonary function test in group B were rellieved obviously. They were statistically significant (P〈0. 05). The inflammatory cells in the induced sputum was decreased obviousely(P〈0.05). Conclusion Asthmatic patients treated with roxithromycin combined with budesonide aerosol have better therapeutic effects.
出处 《淮海医药》 CAS 2007年第4期312-313,共2页 Journal of Huaihai Medicine
关键词 哮喘 罗红霉素 布地奈德 治疗结果 Asthma Roxithromyein Budesonide Treatment outcome
  • 相关文献

参考文献4

二级参考文献11

  • 1Vignola AV, Gagliardo R, Guerrera D, et al. New evidence of inflammation in asthma. Thorax, 2000, 55 (Suppl): 59-60.
  • 2Papavassiliou AG. Transcription factors. N Engl J Med, 1995, 332: 45-47.
  • 3Zeiger RS, Schatz M, Sperling W, et al. Efficacy of troleandomycin in outpatients with severe, conticosteroid-dependent asthma. J Allergy Clin Immunol, 1980, 66:438-446.
  • 4Itkin IH, Menzel ML. The use of macrolide antibiotic substances in the treatment of asthma. J Allergy Clin Immunol, 1970, 45: 146-162.
  • 5Miyatake H, Taki F, Taniguchi H, et al. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest, 1991, 99: 670-673.
  • 6Amayasu H, Yoshida S, Ebana S, et al. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Athma Immunol, 2000, 84: 594-598.
  • 7Barnes PJ, Karin M. Nuclear factor-B: a pivotal transcription factor in chronic inflammatory disease. N Engl J Med, 1997, 336: 1066-1071.
  • 8Hart LA, Krishnan VL, Adcock IM, et al. Activation and localization of transcription factor,nuclear factor-kappa B in asthma. Am J Respir Crit Care Med, 1998, 158: 1585-1592.
  • 9Stacey MA, Sun G, Vassalli G, et al. The allergen Der p1 induced NF-B activation through interference with IB alpha function in asthmatic bronchial epithelial cells. Biochem Biophys Res Commun, 1997, 236: 522-526.
  • 10Jaspers I, Flescher E, Chen LC. Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells. Am J Physiol, 1997, 272: L500-L504.

共引文献3578

同被引文献28

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部